CN¥23.24
1.75%
Shanghai, Sep 28, 03:00 pm CST. Closed.
ISIN
CNE100001M79
Symbol
600196

Shanghai Fosun Pharmaceuti-h Stock price

CN¥23.24
+0.37 1.62% 1M
-3.42 12.83% 6M
-3.25 12.27% YTD
-6.12 20.84% 1Y
-5.36 18.74% 3Y
-33.66 59.16% 5Y
-0.10 0.43% 10Y
+20.26 680.00% 20Y
Shanghai, Closing price Mon, Sep 28 2026
+0.40 1.75%
ISIN
CNE100001M79
Symbol
600196
Industry

Is Shanghai Fosun Pharmaceuti-h a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
CN¥56.7b
Enterprise Value
CN¥80.9b
Net debt
CN¥24.3b
Cash
CN¥15.8b
Shares outstanding
2.7b
Valuation (TTM | estimate)
P/E
17.7
P/S
1.3 | 1.3
EV/Sales
1.9 | 1.9
EV/FCF
115.7
P/B
1.2
Dividends
DPS
CN¥0.39
Yield 1Y | 5Y
1.7% | 1.3%
Growth 1Y | 5Y
21.9% | -1.9%
Payout 1Y | 3Y
25.2% | 31.6%
Increased
2 Years
Financials (TTM | estimate)
Revenue
CN¥42.6b | CN¥43.3b
EBITDA
-
EBIT
CN¥2.9b
Net Income
CN¥3.4b
Free Cash Flow
CN¥699.9m
Growth (TTM | estimate)
Revenue
6.2% | 3.8%
EBITDA
-
EBIT
13.1%
Net Income
4.4%
Free Cash Flow
123.5%
Margin
Gross
50.0%
EBITDA
-
EBIT
6.9%
Net
8.0%
Free Cash Flow
1.6%
Financial Health
Equity Ratio
40.6%
Return on Equity
6.9%
ROCE
3.4%
ROIC
2.6%
Debt/Equity
0.8
More
EPS
CN¥1.3
FCF per Share
CN¥0.3
Short interest
-
Employees
41k
Rev per Employee
CN¥1.0m

Shanghai Fosun Pharmaceuti-h Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Shanghai Fosun Pharmaceuti-h forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Shanghai Fosun Pharmaceuti-h forecast:

Buy
70%
Hold
30%

Financial data from Shanghai Fosun Pharmaceuti-h

Jun '26
+/-
%
42,589 42,589
6% 6%
100%
- Direct Costs 21,283 21,283
0% 0%
50%
21,306 21,306
14% 14%
50%
- Selling and Administrative Expenses 14,280 14,280
10% 10%
34%
- Research and Development Expense 4,383 4,383
25% 25%
10%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,923 2,923
13% 13%
7%
Net Profit 3,390 3,390
4% 4%
8%

In millions CNY.

Don't miss a Thing! We will send you all news about Shanghai Fosun Pharmaceuti-h directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shanghai Fosun Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shanghai, Shanghai and currently employs 40,557 full-time employees. Shanghai Fosun Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of pharmaceutical products. The firm operates in five segments. Pharmaceutical segment is mainly engaged in the manufacturing of innovative drugs, mature pharmaceutical products and vaccines. Medical Devices and Medical Diagnostics segment is mainly engaged in the manufacturing and sales of medical cosmetic devices such as molecular diagnosis, immunodiagnosis, and microbial diagnosis. Medical Health Services segment is mainly engaged in the operation of an online and offline integrated medical service platform. Pharmaceutical Distribution and Retail segment is mainly engaged in the wholesale and retail of pharmaceutical products. Others segment is engaged in other pharmaceutical-related businesses. The firm's products are mainly used in the treatment of tumors, immunity, central nervous system and other fields.

Head office China
CEO Ms. Li
Employees 40,603
Website www.fosunpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today